New Therapies in Cystic Fibrosis Directed Toward the Basic Defect

Volume 4, Issue 8.

In this podcast guest author Steven Rowe, MD, Associate Professor of Medicine from the University of Alabama at Birmingham, describes how CFTR modulator therapy fits into the clinical armamentarium of CF lung disease; identifies which patients are most appropriate for CF modulator treatment; and describes current research efforts and how to identify patients suitable for referral for consideration in CFTR modulator clinical trials.

Leave a Reply

Your email address will not be published. Required fields are marked *